Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
21
GNLN Quote, Financials, Valuation and Earnings
Last price:
$3.56
Seasonality move
:
-10.93%
Day range:
$3.20 - $3.80
52-week range:
$2.84 - $16,354.09
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.33x
P/B ratio:
154.35x
Volume:
480.2K
Avg. volume:
1.8M
1-year change:
-99.85%
Market cap:
$3.6B
Revenue:
$13.3M
EPS (TTM):
-$22,951.04
Earnings Data
Next earnings date for GNLN
Jul 25
2025
Most recent earnings per share
-$240.00
Missed by $240.00
(Mar 31/2025)
Consensus Estimate
--
(Mar 31/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
GNLN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | $1.5M | -$240.00 | -- | -- |
| 03/21/2025 | Q4 | -- | $1.7M | -$3.87 | -- | -- |
| 11/15/2024 | Q3 | -- | $4M | -$3.87 | -- | -- |
| 08/14/2024 | Q2 | -- | $2.7M | -$1.16 | -- | -- |
| 03/31/2024 | Q1 | -- | $4.9M | -$9,487.74 | -- | -- |
| 01/09/2024 | Q4 | -- | $10M | -$9,594.25 | -- | -- |
| 09/30/2023 | Q3 | $21.4M | $11.8M | -$15,757.89 | -- | -- |
| 06/30/2023 | Q2 | $22.6M | $19.6M | -$46,714.00 | -- | -- |
| 03/31/2023 | Q1 | $24M | $24M | -$44,881.12 | -- | -- |
| 03/30/2023 | Q4 | $27M | $22M | -$168,304.21 | -- | -- |
| 11/15/2022 | Q3 | $36.6M | $28.7M | -$1,637,748.44 | -$107,252.67 | -$1,530,495.77 |
| 08/16/2022 | Q2 | $50.6M | $39.9M | -$187,279.68 | -$123,753.08 | -$63,526.60 |
| 05/17/2022 | Q1 | $50.9M | $46.5M | -$280,507.01 | -$154,003.83 | -$126,503.18 |
| 03/30/2022 | Q4 | $57.9M | $56M | -$148,503.71 | -$115,502.88 | -$33,000.84 |
| 11/15/2021 | Q3 | $43.7M | $41.3M | -$675,691.89 | -$126,503.15 | -$549,188.74 |
| 08/17/2021 | Q2 | -- | $34.7M | -$266,481.66 | -- | -- |
| 05/18/2021 | Q1 | -- | $34M | -$462,011.55 | -- | -- |
| 03/31/2021 | Q4 | -- | $36.3M | -$445,511.14 | -- | -- |
| 11/12/2020 | Q3 | -- | $35.8M | -$577,514.44 | -- | -- |
| 08/07/2020 | Q2 | -- | $32.4M | -$297,007.43 | -- | -- |
| 06/04/2020 | Q1 | -- | $33.9M | -$709,517.74 | -- | -- |
| 03/30/2020 | Q4 | -- | $37.2M | -$445,511.14 | -- | -- |
| 11/08/2019 | Q3 | -- | $44.9M | -$1,056,026.40 | -- | -- |
| 08/12/2019 | Q2 | -- | $53M | -$49,501.24 | -- | -- |
| 03/31/2019 | Q1 | -- | $49.9M | -$3,116,521.10 | -- | -- |
| 12/31/2018 | Q4 | -- | $51.6M | -$1,460,692.83 | -- | -- |
| 09/30/2018 | Q3 | -- | $43.6M | -$23,335.45 | -- | -- |
| 06/30/2018 | Q2 | -- | $40.6M | $39,756.70 | -- | -- |
| 03/31/2018 | Q1 | -- | $43.3M | $397,347.28 | -- | -- |
Greenlane Holdings Earnings Questions
-
How Much did Greenlane Holdings Generate in Revenue Last Quarter?
Greenlane Holdings reported $1.5M worth of top line sales in its most recent quarter.
-
Did Greenlane Holdings Beat Earnings Last Quarter?
Greenlane Holdings announced earnings per share of -$240.00 which represents a miss of analyst forecast a -- per share.
-
Is Greenlane Holdings Profitable?
Greenlane Holdings reported $721K that represents $0.00 per share over the last quarter.
-
What is the Analyst Consensus for Greenlane Holdings EPS Next Year?
Greenlane Holdings's earnings are forecast to grow from -$10,920.00 per share to -- per share next year representing an increase of --.
-
When is Greenlane Holdings's Earnings Date?
Greenlane Holdings's next earnings date is July 25, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
